N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide

C29H29N5O5 — CID 1060910

IUPACN-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide
SMILESCOc1ccc(-n2nc(-c3ccccc3)cc2NC(=O)CN(C(=O)c2ccc(C)c([N+](=O)[O-])c2)C(C)C)cc1
InChIInChI=1S/C29H29N5O5/c1-19(2)32(29(36)22-11-10-20(3)26(16-22)34(37)38)18-28(35)30-27-17-25(21-8-6-5-7-9-21)31-33(27)23-12-14-24(39-4)15-13-23/h5-17,19H,18H2,1-4H3,(H,30,35)
InChIKeyOGGJQAMQSBKCGU-UHFFFAOYSA-N
MW527.58 g/mol
LogP5.25
Rot. Bonds9

About N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide

N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide (PubChem CID 1060910) has the molecular formula C29H29N5O5 and a molecular weight of 527.58 g/mol. Its IUPAC name is N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide.

Molecular Properties

Compound NameN-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide
PubChem CID1060910
Molecular FormulaC29H29N5O5
Molecular Weight527.58 g/mol
Exact Mass527.22
IUPAC NameN-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide
SMILESCOc1ccc(-n2nc(-c3ccccc3)cc2NC(=O)CN(C(=O)c2ccc(C)c([N+](=O)[O-])c2)C(C)C)cc1
InChIInChI=1S/C29H29N5O5/c1-19(2)32(29(36)22-11-10-20(3)26(16-22)34(37)38)18-28(35)30-27-17-25(21-8-6-5-7-9-21)31-33(27)23-12-14-24(39-4)15-13-23/h5-17,19H,18H2,1-4H3,(H,30,35)
InChIKeyOGGJQAMQSBKCGU-UHFFFAOYSA-N
XLogP5.25
TPSA119.60 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500527.58
LogP ≤ 55.25
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide?
The IUPAC name of N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide (CID 1060910) is N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide.
What is the SMILES notation for N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide?
The canonical SMILES for N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide is COc1ccc(-n2nc(-c3ccccc3)cc2NC(=O)CN(C(=O)c2ccc(C)c([N+](=O)[O-])c2)C(C)C)cc1.
What is the InChIKey of N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide?
The InChIKey is OGGJQAMQSBKCGU-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H29N5O5/c1-19(2)32(29(36)22-11-10-20(3)26(16-22)34(37)38)18-28(35)30-27-17-25(21-8-6-5-7-9-21)31-33(27)23-12-14-24(39-4)15-13-23/h5-17,19H,18H2,1-4H3,(H,30,35).
What are the key properties of N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide?
N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide has a molecular weight of 527.58 g/mol, XLogP of 5.25, 9 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[[1-(4-methoxyphenyl)-3-phenylpyrazol-5-yl]amino]-2-oxoethyl]-4-methyl-3-nitro-N-propan-2-ylbenzamide is sourced from PubChem (CID 1060910), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).